Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization
- 29 March 2011
- journal article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 283 (6) , 1415-1421
Abstract
The present study aims to compare anti-Mullerian hormone (AMH) with other ovarian reserve markers and to find a cut-off value of AMH for predicting ovarian response towards controlled ovarian hyperstimulation in an in vitro fertilization (IVF) program. A prospective analysis was performed in 180 patients undergoing their first IVF trial, which is being conducted at a department of assisted reproduction in a tertiary medical center. The main outcome measures were determined as age and antral follicle count as well as the serum concentrations of follicle stimulating hormone, luteinizing hormone (LH), estradiol (E2), inhibin B and AMH. The predictive power of the aforementioned measures in specifying ovarian response was determined by means of discriminate analyses. As expected, day 3 LH levels were significantly high in the poor responder group. The poor responders had significantly lower antral follicle counts, retrieved oocyte number, and mature oocyte counts as well as day 3 AMH levels (5.8 ± 2.32 vs. 1.8 ± 0.80 ng/ml). There was a positive correlation with antral follicle count, basal AMH, E2 and follicle count on the day of HCG administration and negative correlation with age. The AMH level was addressed as the only significant factor in determination of mature oocyte number. A cut-off point for serum AMH concentration indicating the value of 2.97 ng/ml was found to predict the poor ovarian response with a sensitivity of 100.0% and a specificity of 89.6%. However, the same cut-off point was not as predictive for the non-conception circumstance. The present study concludes that AMH is a promising biochemical marker for the prediction of ovarian response and that a cut-off point indicating the value of 2.97 ng/ml can be adopted for this prediction.Keywords
This publication has 28 references indexed in Scilit:
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)Human Reproduction Update, 2009
- Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cyclesReproductive Biology and Endocrinology, 2009
- Anti-Müllerian hormone and ovarian dysfunctionTrends in Endocrinology & Metabolism, 2008
- Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)2008
- Ovarian ReserveAnnals of the New York Academy of Sciences, 2008
- Mild ovarian stimulationJournal of Assisted Reproduction and Genetics, 2007
- Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserveFertility and Sterility, 2007
- Early follicular antimüllerian hormone as an indicator of ovarian reserveFertility and Sterility, 2006
- Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilizationFertility and Sterility, 2005
- Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysisFertility and Sterility, 2003